I am a scientist, founder, investor, musician, and visual artist in a perpetual struggle to balance my interests.

Currently, I work as a partner at Triplicate, an early-stage investment firm promoting the deinstitutionalization of science. We are interested in supporting teams that accelerate independent scientific discovery.

I spend a large part of my time thinking about incentive and mechanism design in science. Previously, I co-founded Molecule, a platform that fosters decentralized, modular, and collaborative drug development, where I also served as CSO and CEO. I also co-founded BIO Protocol, a DeFi protocol for the decentralized science ecosystem. I co-authored the VitaDAO white paper, and built a first-of-its-kind collective dedicated to supporting longevity research through a decentralized funding approaches, as well as PsyDAO, doing a similar thing for psychedelic science. Collectively, this space has become known as decentralized science (DeSci).

Prior to being a founder, I worked under the mentorship of Dr. David M. Wilson III and Dr. Vilhelm Bohr at The National Institute on Aging, where I focused on DNA damage and repair and segmental progerias. During my undergraduate studies, I collaborated with Dr. Ron Hutchison and Dr. Daniel Hernandez to examine pathogenesis in limulus egg populations using Next-Generation Sequencing (NGS) and conducted research at Columbia University with Dr. Robert Fine, investigating chemotherapy resistance mechanisms in pancreatic cancer and developing novel therapeutic strategies for various cancers.

I maintain a broad interest in epistemics, game theory, incentive design in science, artificial intelligence, psychedelics, longevity research, frontier technologies, and history amongst other things.

I produce electronic music under the alias Faretrade and visual art under the moniker Scanate.

You can DM me on X.